Controlling the burden of liver disease through integration Hepatitis A and B vaccination into National Immunization programs of the EAC Partner States.

Abstract

Liver cancer is the leading cause of deaths in world. Chronic hepatitis B causes 80% of liver cancer causes in the EAC region. The combination of Aflatoxin exposure with hepatitis infection especially among people, who are malnourished or living with HIV results in a double disease burden that increases disease severity, reduces survivability and heightens liver cancer prevalence. The economic losses of residents of all EAC Partner States associated with morbidity and mortality from Aflatoxin-attributable liver cancer is of high magnitude.